PROTEAPEX THERAPEUTICS
ProteaPex Therapeutics is a biotechnology research firm that develops extracellular matrix protection factors for humans and animals.
PROTEAPEX THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Therapeutics Wellness
Founded:
2011-01-01
Address:
Philadelphia, Pennsylvania, United States
Country:
United States
Website Url:
http://www.proteapextherapeutics.com
Total Employee:
1+
Status:
Active
Contact:
+1 267-544-9799
Email Addresses:
[email protected]
Current Employees Featured
Founder
Official Site Inspections
http://www.proteapextherapeutics.com
- Host name: 192.117.180.107.host.secureserver.net
- IP address: 107.180.117.192
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "ProteaPex Therapeutics"
Proteapex Therapeutics :: Home
Publications. March 23, 2024. ECPF-2 poster presented at American Association for Anatomy in Toronto, Canada. Elastin is the main extracellular matrix protein that gives the alveolar walls their elastic properties.See details»
Proteapex Therapeutics :: About Us
Most recently he was President and CEO of the Center for Animal Health Innovation, an animal health industry led organization providing proof of concept funding to accelerate the development of breakthrough products. Prior to this, he was CEO of BioWizard, a VC funded research and information firm for biomedical scientists.See details»
ProteaPex Therapeutics - Crunchbase Company Profile & Funding
Organization. ProteaPex Therapeutics . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. ... Contact Email [email protected]; Phone Number +1 267-544-9799; Lists Featuring This Company. Edit Lists Featuring This Company Section. Greater Philadelphia Area Wellness Companies .See details»
PROTEAPEX THERAPEUTICS, LLC - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for PROTEAPEX THERAPEUTICS, LLC of Philadelphia, PA. Get the latest business insights from Dun & Bradstreet.See details»
ProteaPex Therapeutics Overview | SignalHire Company Profile
Phone Number: 484-619-3685: ProteaPex Therapeutics industries Biotech: Headquarters Location: 4170 City Avenue, Phialdelphia, PA 19131, Philadelphia, PA, 19131 US 4170 City Avenue, Phialdelp... ProteaPex Therapeutics Employees SizeSee details»
Proteapex Therapeutics LLC - Drug pipelines, Patents, Clinical trials ...
Explore Proteapex Therapeutics LLC with its drug pipeline, therapeutic area, technology platform, .See details»
ProteaPex Therapeutics Company Profile | Management and
Www.proteapextherapeutics.com . ProteaPex Therapeutics Profile and History. ProteaPex Therapeutics has been granted a patent on the "Compositions and Methods for Inhibition of MMP13:MMP-Substrate Interactions" by the US Patent Office. ProteaPex Therapeutics has developed an innovative disease modifying therapeutic technology to treat post ...See details»
Overview, News & Similar companies - ZoomInfo.com
View ProteaPex Therapeutics (www.proteapextherapeutics.com) location in Pennsylvania, United States , revenue, industry and description. Find related and similar companies as well as employees by title and much more. Products. Sales Contact & Company Search Sales Automation Conversation Intelligence Workflows.See details»
Contact Us - Proteapex Therapeutics
Address. ProteaPex Therapeutics, LLC #511C Evans Hall 4170 City Ave Philadelphia, PA 19131 PH:(267) 544-9799 email: [email protected]See details»
ProteaPex Therapeutics: Contact Details and Business Profile
ProteaPex Therapeutics is a Business Services, Biotechnology Research, and Biotechnology company located in Philadelphia, Pennsylvania with $1.00 Million in revenue and 2 employees. Find top employees, contact details and business statistics at RocketReach.See details»
ProteaPex Therapeutics - LinkedIn
4170 City Avenue, Phialdelphia, PA 19131 Room 332 Evans Hall Philadelphia, PA 19131, USSee details»
Nextsource | Company Profile | ProteaPex Therapeutics
Explore the company profile of ProteaPex Therapeutics (proteapextherapeutics.com) featuring business details and insights, funding data, industry info, employee numbers, and more.See details»
ProteaPex Therapeutics Management Team | Org Chart
ProteaPex Therapeutics employs 2 employees. The ProteaPex Therapeutics management team includes Jeffrey Boily (Chairman of the Board-CEO), and Marina D'Angelo (Co-Founder). Get Contact Info for All DepartmentsSee details»
ProteaPex Therapeutics - Contacts, Employees, Board Members, …
ProteaPex Therapeutics is a biotechnology research firm that develops extracellular matrix protection factors for humans and animals.See details»
Proteapex Therapeutics - Products, Competitors, Financials, …
Headquarters Location. 4170 City Avenue, Phialdelphia, Pa 19131 Room 332 Evans Hall. Philadelphia, Pennsylvania, 19131, United StatesSee details»
Proteapex Therapeutics Company Profile -Sales, Contacts, …
Proteapex Therapeutics is in the Pharmaceutical Preparations industry within the Chemicals and Allied Products sector and has been in business for approximately 13 years.See details»
PROTEAPEX THERAPEUTICS LLC Philadelphia PA, 19147 - Cortera
Free Business profile for PROTEAPEX THERAPEUTICS LLC at 1019 Catharine St, Philadelphia, PA, 19147-2701, US. PROTEAPEX THERAPEUTICS LLC specializes in: Pharmaceutical Preparations.See details»
ProteaPex Therapeutics - Biotechnology - Overview ... - Apollo.io
ProteaPex Therapeutics is working on research and development of the Extracellular Matrix Protection Factors (ECPFs). The ECPFs are a platform technology that can be tailored to several members of the Matrix Metalloprotease (MMP) family.See details»
Partners - Proteapex Therapeutics
Our molecule represents a novel, safe, effective and economical approach to management and reversal of the pathology associated with OA. Our company's strategy for developing this OA treatment is to target the veterinary market first for an early exit that will provide supporting clinical data for the human drug FDA application and financial support for the longer …See details»
News - Proteapex Therapeutics
News from 2013. PATENT GRANTED TO PROTEAPEX THERAPEUTICS December 16, 2013 ProteaPex Therapeutics has been granted a patent on the "Compositions and Methods for Inhibition of MMP13:MMP-Substrate Interactions” by the US Patent Office.See details»